Fluorescein

vascular endothelial growth factor A ; Homo sapiens







30 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34649253 The Effect of Selective Retina Therapy for Bevacizumab-Resistant Chronic Central Serous Chorioretinopathy. 2022 1
2 34803132 NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study. 2022 Mar 1 3
3 35109797 Treatment responses for branch retinal vein occlusion predicted by semi-automated fluorescein angiography quantification. 2022 Feb 2 2
4 35191353 Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF. 2022 Feb 22 3
5 33613250 Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration. 2021 Jan-Apr 1
6 33948533 Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab. 2021 Jan-Dec 2
7 35141247 Different Types of Hyperfluorescence Observed in Post Anti-VEGF Fluorescein Angiographic Patterns in Retinopathy of Prematurity Patients. 2021 3
8 32058830 Medical Therapy of Uveitic Macular Edema: Biologic Agents. 2020 Nov 16 1
9 32394732 Optical Coherence Tomography Angiography of Inflammatory Choroidal Neovascularization Early Response after Anti-VEGF Treatment. 2020 Dec 1
10 28291070 FLORID NEOVASCULARIZATION OF THE RETINA IN A DIABETIC PATIENT UNDERGOING INDUCTION AND CONSOLIDATION THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA. 2019 Spring 1
11 30664126 ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION. 2019 Mar 1
12 28176934 Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections. 2017 2
13 28377846 A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study. 2017 Mar 1
14 29727107 Aqueous levels of VEGF correlate with retinal non-perfusion areas in patients with diabetic macular edema and macular edema secondary to central retinal vein occlusion. 2016 Sep 1
15 24698606 Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. 2014 Apr 1
16 24909062 Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies. 2014 Dec 1
17 23185181 Choroidal neovascularization regression on fluorescein angiography after VEGF blockade. 2012 Sep 1
18 21233856 Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells. 2011 Apr 1
19 20237252 Recombinant human VEGF165b inhibits experimental choroidal neovascularization. 2010 Aug 1
20 20452027 Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. 2010 Jul 1
21 18783494 Clinical and histological aspects of CNV formation: studies in an animal model. 2008 Sep 1
22 16977340 [Intravitreal bevacizumab for recurring choroidal neovascularisation]. 2007 Feb 1
23 17175539 Improved nuclear localization of DNA-binding polyamides. 2007 2
24 15509618 VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. 2005 Jan 1
25 15965177 Generation of transgenic mice with mild and severe retinal neovascularisation. 2005 Jul 1
26 12560209 Structural mechanisms of acute VEGF effect on microvessel permeability. 2003 Jun 1
27 12954624 A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. 2003 Nov 21 1
28 11148600 VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. 2000 Aug 1
29 8694732 Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. 1996 Aug 1
30 8942877 Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. 1996 Nov 1